Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

Tissue Antigens

Volumn 55, Issue 2, 2000, Pages 140-148

  Fogdell Hahn, A ^a   Ligers, A ^a   Gronning M ^b   Hillert, J ^a   Olerup, O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

A*0201; A*0301; Allele specific amplification; Autoimmunity; DPB1*0401; Genetic susceptibility; Histocompatibility testing; HLA class I association; Multiple sclerosis; Polymerase chain reaction

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SWEDEN;

ALLELES; AUTOIMMUNE DISEASES; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

ANIMALIA;

EID: 0033975139     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550205.x     Document Type: Article

References (30)

1. 1. Raine CS. Analysis of autoimmune demylination: Its impact upon multiple sclerosis. Lab Invest 1984: 50: 608-35.
2. 2. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992: 10: 153-87.
3. 3. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag Inc., 1985: 152-67.
4. 4. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 1973: 2: 1221-5.
5. 5. Fogdell A, Hillert J, Sachs C, Olerup O. The multiple sclerosis-and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995: 46: 333-6.
6. 6. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1-15.
7. 7. Coraddu F, Reyesyanez MP, Parra A et al. HLA associations with multiple sclerosis in the Canary islands. J Neuroimmunol 1998: 87: 130-5.
8. 8. Amirzargar A, Mytilineos J, Yousefipour A et al. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur J Immunogenet 1998: 25: 297-301.
9. 9. Marrosu MG, Muntoni F, Murru MR et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurol 1988: 38: 1749-53.
10. 10. Marrosu MG, Muntoni F, Murru MR et al. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles. Neurology 1992: 42: 883-6.
11. 11. Ito H, Yamasaki K, Kawano Y et al. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 1998: 52: 179-82.
12. 12. Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl Å, Holmdahl R. Protective influences on Experimental Autoimmune Encephalomyelitis by MHC class I and class II alleles. J Immunol 1994: 153: 3337-44.
13. 13. Aldener-Cannava A, Olerup O. HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations. Tissue Antigens 1996: 48: 153-60.
14. 14. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
15. 15. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
16. 16. Hillert J, Grönning M, Nyland H, Link H, Olerup O. An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psych 1992: 55: 887-90.
17. 17. Svejdaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
18. 18. Fewester M, Myers L, Ellison G, Walford R. Histocompatibility types and measles antibodies in multiple sclerosis. J Neurol Sci 1977: 22: 419-28.
19. 19. Naito S, Namerow N, Mickey M, Terasaki P. Multiple sclerosis: Association with HLA3. Tissue Antigens 1972: 2: 1-4.
20. 20. Stewart G, Basten A, Guinan J, Bashir H, Cameron J, Mcleod J. HLA-Dw2, viral immunity and family studies in multiple sclerosis. J Neurol Sci 1977: 32: 153-67.
21. 21. Madigand M, Oger J, Fauchet R, Sabouraud O, Genetet B. HLA profiles in multiple sclerosis suggests two forms of disease and excistence of protective haplotypes. J Neurol Sci 1982: 53: 519-29.
22. 22. Bertrams H, Kuwert E. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. J Immunol 1976: 117: 1906-12.
23. 23. Ilonen J, Herva E, Reunanen M et al. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis. Acta Neurol Scand 1977: 55: 299-309.
24. 24. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity - viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995: 80: 695-705.
25. 25. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
26. 26. Nepom GT. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990: 39: 1153-7.
27. 27. Trowsdale J, Campbell RD. The 12th international MHC map. In: Charron D, ed. Genetic diversity of HLA - functional and medical implications. Paris: EDK, 1997: 499-504.
28. 28. Worwood M, Chowdhury RR, Robson KJH, Pointon J, Shearman JD, Drake C. The HLA A1-B8 haplotype extends 6 Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markers. Tissue Antigens 1997: 50: 521-6.
29. 29. Ødum N, Hyldig-Nielsen JJ, Morling N, Sandberg-Wollheim M, Platz P, Svejgaard A. HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens 1988: 31: 235-7.
30. 30. Fugger L, Ryder LP, Morling N et al. DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics 1990: 32: 150-6.